Scopus by Title (Ref)

Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among People Who Use Drugs in Turkey

Open Forum Infectious Diseases

1 April 2025

Asan A.

Open Access

Seropositivity Rates of Anti-HCV, HbsAg, Anti-HIV, and the Relationship between Sociodemographic and Clinical Variables in Individuals Hospitalized with a Diagnosis of Opioid Use Disorder

Addicta the Turkish Journal on Addictions

March 2025

Paltun S.C.

Open Access

Hepatitis B virus infection among illegal drug users in Enugu State, Nigeria: prevalence, immune status, and related risk factors

BMC Public Health

December 2024

Orabueze I.N.

Open Access

Seroprevalence and Risk Factors for Hepatitis B, Hepatitis C, and HIV in a Substance Abuse Treatment Center

Journal of Infection in Developing Countries

July 2024

Arıkan H.B.A.

Open Access

A nurse-led, telehealth-driven hepatitis C management initiative in regional Victoria: Cascade of care from referral to cure

Journal of Telemedicine and Telecare

April 2024

Rodrigues B.

Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening

Turkish Journal of Gastroenterology

October 2023

Çekin A.H.

Open Access

Substance Use Disorders and Hepatitis C: A Public Health Issue

Klimik Dergisi

2022

Ceylan M.R.

Open Access

HBsAg, anti-HCV and anti-HIV seroprevalance among drug users: A retrospective assessment

Noropsikiyatri Arsivi

September 2019

Altuğlu İ.

All Open Access, Green

Relationship between syringe sharing and severity of psychopathology, antisocial personality disorder and novelty seeking in a sample of patients with heroin use disorder

Heroin Addiction and Related Clinical Problems

June 2019

Alniak İ.

Hepatitis C virus (HCV) infection in youth with illicit drug use: Sociodemographic evaluation and HCV genotype analysis

Klimik Dergisi

December 2018

Yetim A.

Open Access